Roderick de Greef

Chief Financial Officer (Consultant)
Mr. de Greef has over 20 years experience in a variety of executive positions at private and publicly-held medical technology companies. Mr. de Greef currently provides strategic financial consulting services to a number of life science companies and serves on the boards of several publicly traded companies, including Cambridge Heart, where he serves as its Chairman, Endologix, Inc., and BioLife Solutions. Previously, Mr. de Greef was the EVP and CFO of Cardiac Science having served in that role during a period of rapid revenue growth and through the company's merger with Quinton Cardiology in 2005. Mr. de Greef has a bachelor's degree in economics and international relations from California State University at San Francisco and earned his MBA from the University of Oregon.